Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease

Biol Blood Marrow Transplant. 2018 Mar;24(3S):S7-S14. doi: 10.1016/j.bbmt.2017.12.788.

Authors

Kelli P A MacDonald¹, Brian C Betts², Daniel Couriel³

Affiliations

¹ Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. Electronic address: Kelli.MacDonald@qimrberghofer.edu.au.
² Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffit Cancer Center, Tampa, Florida.
³ Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah.

PMID: 29425517
DOI: 10.1016/j.bbmt.2017.12.788

No abstract available

Keywords: Allogeneic hematopoietic cell transplantation; Chronic GVHD; Graft-versus-host disease; Interleukin-17A; JAK inhibitor.

Publication types

Review